CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » mTOR

Oncology NEWS International. Vol. 11 No. 8
Pages: 1  2  
Next
 

Novel Inhibitor of mTOR Shrinks Cancers by Starving Them

August 1, 2002

SAN FRANCISCO—A novel experimental compound, AP23573, can induce potent tumor shrinkage by inhibiting nutrient uptake in cancer cells and starving them, according to a presentation at the 93rd Annual Meeting of the American Association for Cancer Research (abstract LB95). Mice with implanted tumors treated with AP23573 for 5 days at low doses (0.3 mg/kg/d) showed sustained reduction in tumor volume—a 46% reduction in treated animals vs a 150% increase in untreated animals.

"This is a new approach to cancer treatment that may be applicable to a range of tumor types and may be less toxic than current standard chemotherapies," said Tim Clackson, PhD, lead researcher and senior vice president, Science and Technology, ARIAD Pharmaceuticals, Cambridge, Massachusetts. "It fools cells into thinking that they are in a starvation environment, and they shut down."

In their first studies of AP23573, Dr. Clackson and his colleagues added it to PTEN-deficient prostate cancer and brain tumor cells in culture. The cells soon stopped growing and dividing. The researchers then grafted human brain tumor cells into mice with defective immune systems. They treated the mice with low-dose injections of the compound for 5 days, followed by 9 days off and another 5 days of treatment. Tumor volume shrank 46% in treated mice whether the drug was given orally or in daily or weekly injections.

In the mouse study, the antitumor effects lasted for 2 weeks beyond the treatment period. The antitumor action of AP23573 can be reinitiated with repeated treatments, resulting in continued reduction of tumor volume.

AP23573 can also be given in intermittent dosing that causes less immunosuppression than current drug-dosing regimens. Such dosing may be appropriate for clinical use, Dr. Clackson said.

The compound AP23573 targets the mTOR protein, which has been shown to play a pivotal role in coordinating the uptake of nutrients in cells for growth and cell division, Dr. Clackson said.

"It is like a master switch that detects the presence of nutrients and helps make the decision whether cells should expand or grow. In the absence of nutrients, the mTOR switch is turned off," he said. The AP23573 compound blocks the action of mTOR, inducing a dramatic metabolic arrest that mimics the cellular response to starvation.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





CancerNetwork on Facebook

 


 
TOPIC INDEX

  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GI Cancers
  • GIST
  • GU Cancers
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Hematology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast


More Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Physician Performance Goals Are Great, But Balance Is More Realistic
Jennifer Frank, MD,  May 15, 2012
Performance measurements for physicians are well-intentioned and get me to rethink how I practice. But in the end I won't make the goals, so I'll have to go with balance over perfection.
Designing the Perfect Business Card for Your Medical Practice
C. Noel Henley, MD,  May 11, 2012
Does your business card say anything substantive about the valuable work you do in your practice? Here’s how to re-design your next business card for maximum impact and engagement.
Registered Nurses an Ideal Fit for Primary Care Practices
Audrey "Christie" McLaughlin, RN,  May 10, 2012
Here are four good reasons to hire a registered nurse for your primary care practice …maybe even instead of a medical assistant.
The Five Biggest Medical Practice Marketing Mistakes
James Doulgeris,  May 10, 2012
There are best practices to marketing your practice, but often, success is more about knowing what not to do. Here are the five most common pitfalls …and how to avoid them.
Can You Practice Medicine and Manage Your Practice?
Rosemarie Nelson,  May 9, 2012
Whether you practice alone, or in a group, if you're trying to see patients in this pay-for-volume environment and also run the business of your practice, you may be missing out on important opportunities.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • A 54-Year-Old Woman Notes the Abundant Development of Nonpigmented Hair on Her Ears and Nose
  • Head and Neck Tumors
  • A 45-Year-Old Woman Presents With Severe Back Pain; Examination Reveals Nephrolithiasis
  • A 58-Year-Old Man Presents With Abdominal Pain and Jaundice
  • Treatment of Castration-Resistant Prostate Cancer: Current Options and Novel Therapies
  • Study Highlights Communication "Breakdowns" in Cancer Care
  • Pazopanib (Votrient) Gets FDA Approval for Advanced Soft-Tissue Sarcoma
  • Brain Tumor Vaccine Shows Promise
  • Physical Activity in Cancer Survivors Associated With Better Health Outcomes
  • Treatment of Castration-Resistant Prostate Cancer: Current Options and Novel Therapies
  • New Way to Target B-Cell Lymphomas
  • How I Survived Chemotherapy
  • Lenalidomide Maintenance for Multiple Myeloma Improves Survival
  • Identifying Appropriate Patient Groups and Drug Targets in DLBCL
  • Diffuse Large B-Cell Lymphoma: Current Treatment Approaches
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Treatment of Castration-Resistant Prostate Cancer: Current Options and Novel Therapies
  • Online Support Tool Reduces Depression, Ups QOL in Cancer Patients
  • Physical Activity in Cancer Survivors Associated With Better Health Outcomes
  • Physical Activity in Cancer Survivors Associated With Better Health Outcomes
  • Online Support Tool Reduces Depression, Ups QOL in Cancer Patients
  • Treatment of Castration-Resistant Prostate Cancer: Current Options and Novel Therapies
  • “I’m Not Going to Treat Your Cancer”
  • The Hateful Patient
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs


 

Order Your Copy!
(2010, 13th Edition)

 


 

Please allow 3 – 4 weeks to ship

 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Mtor
Evidence on Mtor
Guidelines on Mtor
Patient Education on Mtor
Clinical Trials on Mtor
Practical Articles on Mtor
Research and Reviews on Mtor
All "Mtor" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy